Jami Rubin
Jami Rubin
attractive based benefits boost improving medicare product rating supports volume
Based on improving new product visibility, benefits from restructuring initiatives, and near-term volume boost from Medicare Part D supports our Attractive rating for the U.S. pharmaceutical sector.
bring couple favor feeling four good group last massively months news overall
My overall feeling is that this group has been massively out of favor for the last four years, but we've actually had a lot of good news in the last couple of months that should bring them into favor.
absolute achieve change
Expectations are at absolute rock-bottom levels. So this is huge. If they actually achieve it, it does change things.
countries deed good lose neither public selling
They're not going to make anything, but neither will they lose anything because they're not selling in those countries anyway. So it's a good public deed on their part, which is why I think most of this is public relations.
bad news norm seen string
Are they going bankrupt? No. But they had a string of bad news like I've never seen before. Bad news has become a norm to the company.
cases evidence far federal scientific standards
Approximately 50% of the cases are filed in the federal court, where standards for scientific evidence are far more rigorous.
conference pay prepare slide
We do this all the time. We pay them for their time. Sometimes they do conference calls. Sometimes they prepare slide shows.
believe clearly damage decline earnings fully largely news next outlook percent price reduction stock though
Though this news is clearly a disappointment, we believe that the damage is largely done and the 10 percent decline in the stock price fully compensates for the approximately 8 percent reduction in the earnings outlook for next year.
completion consent decree financial major positive spending
In addition, we think completion of the company's consent decree obligations is a major psychological positive that could also have financial implications, as spending on consultants and inspections declines.
announced broader cuts expect general longer response sales within
This is in response to a very challenging environment. I would expect broader cuts to be announced within the sales force, marketing, general and (administration) as well as R&D over the longer run.